Souverein, P.

patient antipsychotic fracture dopamine hip /femur fracture hyperprolactinemia agonist dopamine agonists study prevalence incidence prolactinoma index date medium disease dopamine agonist-treated hyperprolactinemia incidence rate /femur women treatment dopamine agonist prolactin antipsychotic use pharmacy property netherland number diagnosis control record index result fracture risk agonist-treated oradj prescription subject endocrinol database analysis effect 182 days antipsychotic drugs idiopathic hyperprolactinemia definition population dopamine agonist users metab medication definition b parkinson incidence rates pharmacy records hyperprolactinemic patients table university association pharmo dopamine agonisttreated hyperprolactinemia dopamine agonist use proportion evidence lactation cabergoline schizophrenia level osteoporo femur person-year risperidone pharmo network period antipsychotic users hip fracture casecontrol study van staa duration pivonello r utrecht exposure